Patents by Inventor Morikazu Onji

Morikazu Onji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF INDUCING IMMUNE TOLERANCE COMPRISING ADMINISTERING CARBONIC ANHYDRASE I
    Publication number: 20140170173
    Abstract: The purpose of the present invention is to provide a method for treating autoimmune diseases. Disclosed is a method or the like for the treatment of autoimmune diseases, which utilizes an antigen-specific tolerogenic antigen presenting cell. Specifically disclosed are: a method for producing an antigen-specific tolerogenic antigen presenting cell, which is characterized by using carbonic anhydrase I; an immunogenic antigen presenting cell which is specific to carbonic anhydrase I; and a method or the like for the treatment of autoimmune diseases (especially inflammatory bowel diseases), which is characterized by using a tolerogenic antigen presenting cell which is specific to carbonic anhydrase I.
    Type: Application
    Filed: December 5, 2013
    Publication date: June 19, 2014
    Applicant: NATIONAL UNIVERSITY CORPORATION EHIME UNIVERSITY
    Inventors: Hidehiro MURAKAMI, Hirofumi YAMANISHI, Morikazu ONJI
  • CARBONIC ANHYDRASE I SERVING AS NOVEL ANTIGEN TO BE USED FOR TREATMENT OF AUTOIMMUNE DISEASES
    Publication number: 20120213808
    Abstract: The purpose of the present invention is to provide a method for treating autoimmune diseases. Disclosed is a method or the like for the treatment of autoimmune diseases, which utilizes an antigen-specific tolerogenic antigen presenting cell. Specifically disclosed are: a method for producing an antigen-specific tolerogenic antigen presenting cell, which is characterized by using carbonic anhydrase I; an immunogenic antigen presenting cell which is specific to carbonic anhydrase I; and a method or the like for the treatment of autoimmune diseases (especially inflammatory bowel diseases), which is characterized by using a tolerogenic antigen presenting cell which is specific to carbonic anhydrase I.
    Type: Application
    Filed: October 7, 2010
    Publication date: August 23, 2012
    Applicant: National University Corporation Ehime University
    Inventors: Hidehiro Murakami, Hirofumi Yamanishi, Morikazu Onji
  • METHOD FOR INDUCING CYTOTOXIC T-CELLS, CYTOTOXIC T-CELL INDUCER, AND PHARMACEUTICAL COMPOSITION AND VACCINE EMPLOYING SAME
    Publication number: 20110206711
    Abstract: A method for inducing cytotoxic T-cells that includes binding to an HLA molecule on the surface of a cell that is a target of a cytotoxic T-cell a peptide containing one or more types of amino acid sequence selected from the group consisting of SEQ ID NOS: 1 to 13 and consisting of not less than 8 and not more than 11 amino acid residues, or a peptide derived from a precursor thereof.
    Type: Application
    Filed: February 16, 2007
    Publication date: August 25, 2011
    Applicants: NEC CORPORATION, KOCHI UNIVERSITY, EHIME UNIVERSITY
    Inventors: Tomoya Miyakawa, Keiko Udaka, Morikazu Onji